Literature DB >> 3085950

Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man.

T Yaginuma, A Avolio, M O'Rourke, W Nichols, J J Morgan, P Roy, D Baron, J Branson, M Feneley.   

Abstract

Effects of sublingual glyceryl trinitrate (GTN) were studied in ten patients without heart failure during diagnostic cardiac catheterisation following angiography. GTN caused substantial reduction in peak left ventricular and aortic pressure (19 mmHg) with lesser reduction in mean aortic pressure (9 mmHg) and no change in diastolic aortic pressure. Reduction in stroke volume (by 15%), associated with fall in left ventricular end diastolic pressure (by 4 mmHg) was insufficient to explain the marked (17 mmHg - 34%) reduction in pulse pressure. Decrease in pulse pressure was associated with loss of the late systolic peak on both the aortic and left ventricular pressure wave. This peak is caused by pulse wave reflection. GTN caused no change in peripheral resistance or in indices of aortic compliance (characteristic impedance, total arterial compliance) but was associated with reduction in fluctuations of both modulus and phase of aortic impedance. All these changes in pressure waves and in impedance spectra are explicable on the basis of decreased peripheral wave reflection. This can be attributed to the known vasodilatory effect of GTN on the peripheral arteries. Simulation of arterial vasodilatation in a multi-branched model of the systemic arterial system confirmed this interpretation. Dilatation of peripheral arteries explains in part the beneficial effects of GTN in adult man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085950     DOI: 10.1093/cvr/20.2.153

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  31 in total

Review 1.  Pulse wave analysis.

Authors:  M F O'Rourke; A Pauca; X J Jiang
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

Review 2.  Diastolic pressure, systolic pressure, or pulse pressure?

Authors:  C Vlachopoulos; M O'Rourke
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 3.  Pulse wave mechanics revisited: relevance to therapy of cardiovascular disease with calcium antagonists.

Authors:  M F O'Rourke
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

Review 4.  Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Authors:  Michael F O'Rourke; Audrey Adji; Mayooran Namasivayam; Jonathan Mok
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

Review 5.  Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece.

Authors:  C Vlachopoulos; K Aznaouridis; C Stefanadis
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

Review 6.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

7.  Effects of sublingual nitroglycerin on working conditions of the heart and arterial system: analysis using wave intensity.

Authors:  Kiyomi Niki; Motoaki Sugawara; Dehua Chang; Akimitsu Harada; Takashi Okada; Rie Tanaka
Journal:  J Med Ultrason (2001)       Date:  2005-12       Impact factor: 1.314

Review 8.  The treatment of heart failure--what next?

Authors:  R H Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

9.  Thermoregulatory vasoconstriction increases the difference between femoral and radial arterial pressures.

Authors:  J Urzua; D I Sessler; G Meneses; C M Sacco; R Canessa; G Lema
Journal:  J Clin Monit       Date:  1994-07

10.  Afterload reduction by hydralazine in children with a ventricular septal defect as determined by aortic input impedance.

Authors:  H Endo; H Shiraishi; M Yanagisawa
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.